Medical devices, healthcare technology and the business of care
PMA approval · P090018

ESTEEM TOTALLY IMPLANTABLE HEARING SYSTEM

Envoy Medical Corporation · Decision date Mar 17, 2010

FDA DECISIONP090018

What did the FDA approve?

FDA records P090018 as an original PMA application. The recorded decision is approval, dated Mar 17, 2010.

FDA approval order statement

APPROVAL FOR THE ESTEEM. THE ESTEEM IS INTENDED TO ALLEVIATE HEARING LOSS IN PATIENTS BY REPLICATING THE OSSICULAR CHAIN AND PROVIDING ADDITIONAL GAIN. THE ESTEEM IS INDICATED FOR PATIENTS WITH HEARING LOSS THAT MEET THE FOLLOWING CRITERIA: 1) 18 YEARS OF AGE OR OLDER;2) STABLE BILATERAL SENSORINEURAL HEARING LOSS;3) MODERATE TO SEVERE SENSORINEURAL HEARING LOSS DEFINED BY PURE TONE AVERAGE (PTA);4) UNAIDED SPEECH DISCRIMINATION TEST SCORE GREATER THAN OR EQUAL TO 40%;5) NORMALLY FUNCTIONING EUSTACHIAN TUBE;6) NORMAL MIDDLE EAR ANATOMY;7) NORMAL TYMPANIC MEMBRANE;8) ADEQUATE SPACE FOR ESTEEM IMPLANT DETERMINED VIA A HIGH RESOLUTION CT SCAN; AND9) MINIMUM 30 DAYS OF EXPERIENCE WITH APPROPRIATELY FIT HEARING AIDS.
Regulatory pathway
Original PMA
Clinical specialty
Ear, Nose, Throat
Decision date
Mar 17, 2010

FDA source record

Regulatory record facts

Identifier
P090018
Regulatory pathway
Premarket approval application
Product code
OAF
Decision code
APPR
Decision date
Mar 17, 2010
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implant, hearing, active, middle ear, totally implanted.

Product code
OAF
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P090018 received

    Application receipt date recorded by FDA.

  2. P090018 · FDA decision

    APPR

Timeline entries are records held by MedtechLedger for P090018. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P090018

Product / regulatory recordCompanyPathwayDecision dateSource
EsteemP090018/S044
Envoy Medical CorporationPMA supplementOct 15, 2026FDA

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Envoy Medical Corporation

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
4875 White Bear Pkwy., White Bear Lake, MN, 55110

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records